This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
FENBENDAZOLE – MEBENDAZOLE
Les Onconautes
Fenbendazole, aspirine, curcuma… : ces molécules qui ont prouvé leur efficacité contre le cancer !
The Fenbendazole Miracle
Oral Fenbendazole for Cancer Therapy in Humans and Animals
Fenbendazole as a Potential Anticancer Drug
Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer Through Dual Targeting of Cancer Cells and Cancer Stem Cells
Fenbendazole Enhancing Anti-Tumor Effect
Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients
Evaluation of anti-parasitic agents as potential therapeutics in ovarian cancer
Treating Aggressive Brain Tumors with the Combo Bumetanide : Mebendazole
Repurposing Mebendazole as a Replacement for Vincristine for the treatment of Brain tumors
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
Mebendazole as a Candidate for Drug Repurposing in Oncology
A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer
Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort